Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Active not recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 8Pancreatic Neoplasms 7Neoplasms 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Colorectal Neoplasms 3Stomatitis 2Skin Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia, Myeloid, Acute 2Leukemia 2Inflammation 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Primary Myelofibrosis 1Myofibroma 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Motor Activity 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1

Interventions

Temozolomide 203Radiotherapy 118Bevacizumab 93Radiation 40Magnetic Resonance Spectroscopy 28Irinotecan 27Carmustine 25Surgical Procedures, Operative 24Lomustine 21Erlotinib Hydrochloride 19Chemotherapy, Adjuvant 18Carboplatin 17temsirolimus 13Drug Therapy 13O(6)-benzylguanine 12Nivolumab 12sargramostim 11Sirolimus 11Radiotherapy, Intensity-Modulated 11Radiotherapy, Conformal 11Sorafenib 10Radiosurgery 10Imatinib Mesylate 10Everolimus 10pembrolizumab 9motexafin gadolinium 9Vorinostat 9Thalidomide 8IL13-PE38 8Gefitinib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Glioblastoma × Ascorbic Acid × Clear all
NCT01752491 2024-12-20

A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme

University of Iowa

Phase 1 Completed
13 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡